ZOLADEX
Google image searchProduct monograph
Active ingredient
goserelin (goserelin acetate), 3.6 MG
DIN: 02049325
Dosage form(s): IMPLANT
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription
Company: TERSERA THERAPEUTICS LLC
Date: 28-FEB-2018
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02A — HORMONES AND RELATED AGENTS (ATC, ATC/DDD)
- L02AE — Gonadotropin releasing hormone analogues (ATC, ATC/DDD)
- L02AE03 — GOSERELIN (ATC/DDD)
Reference brand drug: Goserelin
